Cited by 266Hormonal and reproductive studiesHypothalamic control of reproductive hormonesSperm and Testicular Function

Ageing of the Hypothalamo-Pituitary- Testicular Axis in Men

Vermeulen, A., Kaufman, J.M.·2008·Hormone Research

Abstract

In distinction to the course of reproductive ageing in women, men do not experience a rapid decline of Leydig cell function or irreversible arrest of reproductive capacity in old age. Hence, strictu sensu, the andropause does not exist. Nevertheless, both spermatogenesis and fertility as well as Leydig cell function do decline with age, as shown by a decrease of ± 35% of total and of 50% of free testosterone levels between the age of 20 and 80 years. The origin of this decline of Leydig cell function resides on the one hand in the testes, and is essentially characterized by a decreased number of Leydig (and Sertoli) cells and on the other hand in the hypothalamo-pituitary complex characterized by a decreased luteinzing hormone (LH) pulse amplitude, LH pulse frequency being maintained. As the responsiveness of the gonadotrophs to gonadotropin-releasing hormone (GnRH) remains unimpaired, one may assume that the amount of GnRH released at each pulse is also reduced, possibly as the consequence of a reduction of the cellular mass of GnRH neurones. Plasma levels of testosterone below the lower normal limit occur, however, only in a minority of elderly men from 7% in the age group 40-60, to 20% in the age group 60-80 and 35% in the age group over 80 years old. Factors influencing testosterone levels in elderly men are multiple: hereditary, environmental (obesity, stress), psychosocial (depression, smoking, drugs) or socioeconomical (diet, hygiene). Whether these elderly men should be substituted with androgens remains controversial. Beneficial effects, such as an increased feeling of well-being and fitness, increased muscle strength and endurance, decreased bone catabolism and increase of hematocrit, should be weighed against the risks of stimulation of growth of an occult, subclinical prostatic carcinoma (occurring with a high frequency in elderly males). Therefore, large scale androgen supplementation should await the results of well-controlled prospective studies.

Integrity signals

Registry

Crossref · 10.1159/000184233

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The prevalence of overt biochemical hypogonadism in 830 men with proven coronary artery disease at angiography was 23.4%, approximately three times higher than the background healthy community prevalence.

    “the overall prevalence of overt biochemical hypogonadism in 830 men with proven coronary artery disease at angiography was 23.4%, 9 which is approximately three times higher than the background healthy community prevalence.10”

Cited by

Sorted by citations

Authors
Vermeulen, A., & Kaufman, J. M.
Affiliations
Ghent University Hospital (BE)
Venue
Hormone Research
Publisher
S. Karger AG
Published
2008-12-05
Volume
43
Issue
1-3
Pages
25-28
ISSN
  • 0301-0163 (ISSN-L)
  • 1423-0046
OpenAlex
W2025587852
Cited by
265
References
0
Citations by year
2025: 2 · 2024: 1 · 2023: 7 · 2022: 5 · 2021: 5 · 2020: 2 · 2019: 8 · 2018: 3 · 2017: 2 · 2016: 2 · 2015: 6 · 2014: 5 · 2013: 8 · 2012: 8
FWCI
8.44
Type
journal article
Language
en
Open access
closed
Locations
  • Hormone Research (publishedVersion)
  • PubMed (publishedVersion)
  • Ghent University Academic Bibliography (Ghent University) (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
  • Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
Keywords
andropause, Leydig cell function, spermatogenesis, male fertility, free testosterone, luteinizing hormone pulsatility, GnRH neurons, testosterone replacement therapy, older men
MeSH terms
Adult, Aged, Aging, Androgens, Hormones, Humans, Hypogonadism, Hypothalamo-Hypophyseal System, Leydig Cells, Luteinizing Hormone, Male, Middle Aged, Testis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review